INTRODUCTION {#sec1-1}
============

Chemically, lafutidine is 2-\[(2-furyl methyl) sulfinyl\]-*N*-(2z-4-{\[4-(piperridin-1yl methyl) pyridin-2-yl\] oxy} but-2-en-1-yl) acetamide \[[Figure 1](#F1){ref-type="fig"}\].\[[@ref1]\] It is a H~2~ receptor antagonist and is reported to show potent and long lasting antagonisms of histamine H~2~ receptor mediated effect. It is effective agonist the esophageal lesions induced by acid reflux through inhibition of acid secretion.\[[@ref2]\] Analysis is an important component in the formulation development of any drug molecule. It becomes essential to develop a simple, sensitive, accurate, precise, reproducible method for the estimation of drug samples. Our main concern is development and validation\[[@ref1]\] of UV spectrophotometric method as per ICH guideline.\[[@ref3]\]

![Chemical structure of lafutidine](PMeth-2-264-g001){#F1}

Earlier publications have described HPLC\[[@ref4]\] and LC--MS\[[@ref5]\] methods for quantification of lafutidine in human plasma and pharmaceutical dosage form. However, these methods involve arduous sample preparation and long chromatographic rum times for biological samples.

So far to our present knowledge, no UV spectrophotometric analytical method is available in literature for analyzing lafutidine in pharmaceutical dosage form or as bulk drug sample. It was felt necessary to develop a simple, precise and rapid method for quantitative determination of lafutidine. The current research work deals with the development of spectrophotometric method and its validation as per International Conference on Harmonisation (ICH) guidelines.\[[@ref3]\]

MATERIALS AND METHODS {#sec1-2}
=====================

Experimental {#sec2-1}
------------

### Instrument and materials {#sec3-1}

Instrument used were Schimadzu 1800 double beam UV/Visible Spectrophotometer and schimadzu 1600 analytical balance. Lafutidine pure drug was obtain from Ajanta Pharmaceuticals Ltd., Mumbai, India as gift sample with 99.9% (w/w) assay value and was used without further purification. All chemicals and reagents used were of analytical grade.

Methodology {#sec2-2}
-----------

### Preparation of standard stock solution {#sec3-2}

Standard drug solution of lafutidine was prepared by dissolving 10 mg lafutidine in 5 ml methanol this solution was transferred it to 10 ml volumetric flask and volume was made up to mark with distilled water to obtain stock solution of 1 mg/ml concentration.

### Preparation of calibration curve {#sec3-3}

Aliquots of 1--5 ml portion of stock solutions were transferred to series of 100 ml volumetric flasks, and volume made up to mark with distilled water. Solutions were scanned in the range of 200--400 nm against blank. The absorption maxima were found to be at 279 nm against blank. The calibration curve was plotted. The optical characteristics are summarized in [Table 1](#T1){ref-type="table"}.

###### 

Calibration curve parameter

![](PMeth-2-264-g002)

### Preparation of sample solution {#sec3-4}

The proposed method was applied to analyze commercially available lafutidine tablet. Ten tablets were weighed and powdered. The amount of tablet powder equivalent to 10 mg of lafutidine was weighed accurately and transfer to 10 ml volumetric flask then 5 ml methanol was added and kept for 15 min with frequent shaking and volume was made up to mark with distilled water. The solution was then filtered through Whattman filter paper \#41. This filtrate was diluted suitably with distilled water to get the solution of 10 μg/ ml concentration. The absorbance was measured against solution blank. The drug content of the preparation was calculated using standard calibration curve. Amount of drug estimated by this method in [Table 2](#T2){ref-type="table"}.

###### 

Determination of accuracy by percentage recovery method
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RESULT AND DISCUSSION {#sec1-3}
=====================

Linearity {#sec2-3}
---------

The linearity of the response of the drug was verified at 10--50 μg/ml concentrations. The calibration curve was obtained by plotting the absorbance versus the concentration data and was treated by linear regression analysis \[[Table 3](#T3){ref-type="table"}\]. The equation of the calibration curve for lafutidine obtained was y = 0.0100x + 0.035, the calibration curve was found to be linear in the aforementioned concentrations (the correlation coefficient (r^2^ ) of determination was 0.999) \[Figure [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}\].

###### 

Validation parameters

![](PMeth-2-264-g004)

![Calibration curve](PMeth-2-264-g005){#F2}

![Overlay figure of linearity ranges of lafutidine (10--50 μg/ml)](PMeth-2-264-g006){#F3}

Precision {#sec2-4}
---------

Assay of method precision (intraday precision) was evaluated by carrying out six independent assays of test samples of lafutidine. The intermediate precision (interday precision) of the method was also evaluated using two different analysts, systems and different days in the same laboratory. The relative standard deviation (RSD) and assay values obtained by two analysts were 0.28, 99.67, and 0.26, 99.68, respectively \[[Table 4](#T4){ref-type="table"}\].

###### 

Determination of precision
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Accuracy (recovery test) {#sec2-5}
------------------------

Accuracy of the method was studied by recovery experiments. The recovery experiments were performed by adding known amounts of the drugs in powdered tablets. The recovery was performed at three levels, 80, 100, and 120% of lafutidine standard concentration. The recovery samples were prepared in afore mentioned procedure. Three samples were prepared for each recovery level. The solutions were then analyzed, and the percentage recoveries were calculated from the calibration curve. The recovery values for lafutidine ranged from 100.1 ± 0.07611% \[[Table 2](#T2){ref-type="table"}, [Figure 4](#F4){ref-type="fig"}\].

![Overlay UV spectra of lafutidine standard and test tablet from 200-400 nm](PMeth-2-264-g008){#F4}

Limit of detection and limit of quantification {#sec2-6}
----------------------------------------------

The Limit of detection (LOD) and limit of quantification (LOQ) of lafutidine were determined by using standard deviation of the response and slope approach as defined in ICH guidelines. The LOD and LOQ for lafutidine are described in [Table 3](#T3){ref-type="table"}.

Determination of active ingredients in tablets {#sec2-7}
----------------------------------------------

The validated method was applied for the determination of lafutidine in tablets (six tablets were assayed and the results in [Table 2](#T2){ref-type="table"} indicate that the amount of drug in tablet samples met with requirements (98%--102% of the label claim).

CONCLUSION {#sec1-4}
==========

The developed UV spectrophotometric method was found to be rapid, simple, inexpensive, reproducible, and applicable over a wide concentration range with high precision and accuracy. The method was validated as per the guidelines laid by ICH. The results of the validated tests were found to be satisfactory and therefore this method can be applied successfully for routine quality control analysis of lafutidine in bulk and pharmaceutical formulation.
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